United States Securities and Exchange Commission · EDGAR Accession 0001872856-26-000151

Form C/A

Offering Statement Amendment — Regulation Crowdfunding
Campaign file 020-36737
Issuer CIK 2103503
Raising via DEALMAKER SECURITIES LLC

BioXgen Holdings, Inc.

CorporationDEIncorporated 2025TUCSON, AZbioxgen.life
Nature of amendmentThis material amendment is filed to include FYE 2025 reviewed financials and update the Offering Deadline.
A

The Offering

as disclosed in this filing
Other (Units of the Co-Issuer corresponding with Class C Common Stock of the Issuer)
$1.43
$25,000
$1,235,000
January 8, 2027
208 days remaining
$0max $1,235,000

Target is 2% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Pre-revenueDebt / assets 279%0 employees
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(290,450)0
Total assets158,5240
Cash & equivalents143,970160,000▼ 10%
Accounts receivable00
Short-term debt80,7240
Long-term debt362,2500
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.

C

Campaign Timeline

file 020-36737 · all filings under this campaign
Loading campaign history…